Jen Herbach

CEO & Co-Founder, Adventris Pharmaceuticals

Co-founder

Adventris Pharmaceuticals· Winter 2023 🇺🇸 San Francisco, California, United States

in LinkedIn

2022Co-founder· Adventris Pharmaceuticals

Founder · since 2022

Company

Adventris Pharmaceuticals

Role

CEO & Co-Founder

current

Stage

—

no public source

Raised

—

no public source

Based

—

Founder / co-founder — the company's markEmployee / research role

Source: LinkedIn work history

Profile coverage5 of 7 · missing posts, contact

Adventris Pharmaceuticals

Adventris makes cancer vaccines

Winter 2023

Experience

Career

Adventris Pharmaceuticals
Co-founder
CEO & Co-Founder · 2022 – Present
2022
Amunix
Director, Corporate Development & Product Strategy · 2019 – 2022
2019
FLX Bio, Inc.
Business Development Consultant · 2018 – 2019
2018
Exelixis
Director of Marketing · South San Francisco, CA · 2016 – 2018
2016
Clovis Oncology
Senior Manager, Value Marketing · San Francisco Bay Area · 2015 – 2016
2015
InterMune
Senior Product Manager, Managed Markets & Patient Access Marketing · San Francisco Bay Area · 2014 – 2015
2014
Onyx Pharmaceuticals
Manager, Market Access & Pricing · South San Francisco, CA · 2013 – 2014
2013
Genentech
MBA Intern - Pulmozyme Marketing · South San Francisco, CA · 2012
2012
Essex Woodlands Health Ventures
Intern · 2010
2010
Close Concerns
Associate · 2009
2009
Barclays Capital
Equity Research Analyst · 2008 – 2009
2008
Lehman Brothers
Equity Research Analyst · 2007 – 2008
2007
Lehman Brothers
Summer Analyst · 2006
2006
Houlihan Lokey
Summer Analyst · 2005
2005
United States Senate
Legislative Intern · 2005
2005
Childrens Hospital Los Angeles
Research Assistant · 2001 – 2003
2001
Cornell University
Research Assistant · 2002
2002

Bio

Jen Herbach is the CEO of Adventris Pharmaceuticals. She has more than a decade of biotech industry experience bringing novel oncology drugs to market, across companies including Onyx/Amgen, InterMune/Genentech, Exelixis, and Amunix. She holds an MBA from Harvard Business School and a Masters from the University of Cambridge.